Outlook Therapeutics (OTLK) Q2 2025 Earnings

15MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.03
-0.82
-0.61
-0.4

Details

Expected EPS
-0.54282
Actual EPS
-0.4
Surprise EPS
0.14
Surprise Percent
+26.31%

Description

Outlook Therapeutics (OTLK) has reported earnings of -0.4 per share for Q2 2025.

0 Comments

Share your thoughts